SAN

79.02

+1.48%↑

SHL.DE

41.42

-0.22%↓

ORNBV.FI

69.3

+0.36%↑

QDEL

23.6

-1.83%↓

ACB

3.76

+5.92%↑

SAN

79.02

+1.48%↑

SHL.DE

41.42

-0.22%↓

ORNBV.FI

69.3

+0.36%↑

QDEL

23.6

-1.83%↓

ACB

3.76

+5.92%↑

SAN

79.02

+1.48%↑

SHL.DE

41.42

-0.22%↓

ORNBV.FI

69.3

+0.36%↑

QDEL

23.6

-1.83%↓

ACB

3.76

+5.92%↑

SAN

79.02

+1.48%↑

SHL.DE

41.42

-0.22%↓

ORNBV.FI

69.3

+0.36%↑

QDEL

23.6

-1.83%↓

ACB

3.76

+5.92%↑

SAN

79.02

+1.48%↑

SHL.DE

41.42

-0.22%↓

ORNBV.FI

69.3

+0.36%↑

QDEL

23.6

-1.83%↓

ACB

3.76

+5.92%↑

Kodu・Aktsiate loetelu・Nanobiotix

N
Nanobiotix

Suletud

22.4 -1.54

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

22.2

Max

23.35

Põhinäitajad
By Trading Economics
Sissetulek	-5.4M
Müük	27M
Kasumimarginaal	-20.208
Töötajad	103
EBITDA	1.1M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+0.66% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	1. apr 2026

Turustatistika
By TradingEconomics
Turukapital	1B
Eelmine avamishind	23.94
Eelmine sulgemishind	22.4

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

2.975 / 3.015 Toetus ja vastupanu

Nanobiotix Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

19. veebr 2026, 23:47 UTC

Market Talk

Global Equities Roundup: Market Talk

19. veebr 2026, 23:47 UTC

Market Talk

Nikkei May Decline Amid Caution Over Potential U.S. Strike on Iran -- Market Talk

19. veebr 2026, 23:39 UTC

Omandamised, ülevõtmised, äriostud

Swiss Re Corporate Solutions to Buy QBE Insurance's Global Trade Credit and Surety Business >SREN.EB

19. veebr 2026, 23:38 UTC

Tulu

Samsung Fire & Marine Insurance 2025 Net KRW2.020T Vs. Net KRW2.077T >000810.SE

19. veebr 2026, 23:38 UTC

Tulu

Samsung Fire & Marine Insurance 2025 Oper Pft KRW2.659T Vs. Pft KRW2.650T >000810.SE

19. veebr 2026, 23:38 UTC

Tulu

Samsung Fire & Marine Insurance 2025 Rev KRW24.779T Vs. KRW22.657T >000810.SE

19. veebr 2026, 23:37 UTC

Market Talk

Gold Edges Lower on Possible Position Adjustment -- Market Talk

19. veebr 2026, 23:34 UTC

Tulu

Samsung Fire & Marine Insurance 4Q Net Profit Missed FactSet-Compiled Consensus

19. veebr 2026, 23:34 UTC

Tulu

Samsung Fire & Marine Insurance 4Q Net KRW234.38B Vs. Net KRW207.88B >000810.SE

19. veebr 2026, 23:33 UTC

Tulu

Samsung Fire & Marine Insurance 4Q Oper Pft KRW391.26B Vs. Pft KRW252.81B >000810.SE

19. veebr 2026, 23:33 UTC

Tulu

Samsung Fire & Marine Insurance 4Q Rev KRW6.083T Vs. KRW6.297T >000810.SE

19. veebr 2026, 22:13 UTC

Market Talk

Goodman's Lack of Earnings Upgrade 'Largely Timing Related' -- Market Talk

19. veebr 2026, 22:08 UTC

Tulu

Fairfax Financial 4Q Rev $8.11B >FFH.T

19. veebr 2026, 22:07 UTC

Tulu

Eldorado Gold 4Q EPS $1.19 >ELD.T

19. veebr 2026, 22:06 UTC

Tulu

Centerra Gold: 2026 Consolidated Gold Production Expected 250,000 to 280,000 Ounces, Copper Production Expected 50M to 60M Pounds >CG.T

19. veebr 2026, 22:05 UTC

Tulu

Eldorado Gold 4Q Adj EPS 63c >ELD.T

19. veebr 2026, 22:05 UTC

Tulu

Eldorado Gold 4Q Rev $577.2M >ELD.T

19. veebr 2026, 22:04 UTC

Tulu

Eldorado Gold 4Q Gold Sales 126,923 Ounces >ELD.T

19. veebr 2026, 22:04 UTC

Tulu

Eldorado Gold 4Q Gold Production 123,416 Ounces >ELD.T

19. veebr 2026, 21:50 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

19. veebr 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

19. veebr 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

19. veebr 2026, 21:43 UTC

Tulu

St Barbara 1H Underlying Profit A$1.3 Million Vs A$48.1 Million Loss Year Earlier

19. veebr 2026, 21:42 UTC

Omandamised, ülevõtmised, äriostud

Palo Alto Networks Announces Offer to Purchase Relating to CyberArk Software Ltd.'s 0.00% Convertible Senior Notes Due 2030

19. veebr 2026, 21:42 UTC

Tulu

St Barbara 1H Revenue A$128.8 Million, Up 32% On-Year

19. veebr 2026, 21:41 UTC

Tulu

Correct: St Barbara 1H Net Loss A$249,000

19. veebr 2026, 21:40 UTC

Tulu

St Barbara 1H Net Loss A$249 Million

19. veebr 2026, 21:39 UTC

Tulu

Perseus Mining Reaffirms FY26 Production, AISC Guidance

19. veebr 2026, 21:37 UTC

Tulu

These Stocks Are Today's Movers: Walmart, Occidental, Klarna, Wayfair, Deere, Omnicom, EPAM, and More -- Barrons.com

19. veebr 2026, 21:37 UTC

Tulu

Century Aluminum Expects 1Q Adj EBITDA $215 M to $235 M >CENX

Võrdlus sarnastega

Hinnamuutus

Nanobiotix Prognoos

Hinnasiht

By TipRanks

0.66% tõus

12 kuu keskmine prognoos

Keskmine 23 EUR 0.66%

Kõrge 23 EUR

Madal 23 EUR

Põhineb 1 Wall Streeti analüütiku instrumendi Nanobiotix 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Nanobiotix aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.975 / 3.015Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.